Hang tight my friend, this is a long term play that needs to carry out its mission. There are many of us that were here in early december/January that bought in at .0023 all the way up to .01. we saw this go to .016 and back down to here. Our good friend Meach said it best, this is a catalyst driven stock, when the catalyst hits (FDA approval), this will be unstoppable. Throw in the Min Gene Silencing FDA Ind and this is huge, Couple that with all the other possible uses for Hemaxellerate and this is a stock you will play for years. I also have a sneaky feeling that there is more in the pipeline. Rock on, you are a lucky trader if this is your first play, I lost my arse on my first couple of plays, im just happy i found this one. Patience is the play here! GLTY.
Hang tight my friend, this is a long term play that needs
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
FirstEnergy Appoints Key Execs: Tech and Safety Push
Well, ain't that a twist in the grid! FirstEnergy just reshuffled the deck, pulling in fresh senior blood to shake things up in safety, technology, and efficiency. It’s a bold move that should raise more than a few investor eyebrows. Meet the New Guards: Energizing FirstEnergy On the helm of this ambitious push, you have Chris Beam, Hanneke Counts, and Daniel Puscas...
Continue Reading
Axos Clearing Teams Up with Envestnet for Enhanced Solutions
Axos Clearing Partners with Envestnet Axos Clearing, a subsidiary of Axos Financial Inc. (NYSE: AX), has recently formed an exciting strategic partnership with Envestnet, a leading provider of integrated technology and wealth solutions. This collaboration promises to deliver cutting-edge managed account solutions directly into Axos Clearing's Axos Complete portal,...
Continue Reading
Foresight Group Holdings Undertakes Strategic Share Buyback Initiative
Foresight Group's Share Buyback Program Overview Foresight Group Holdings Limited, renowned for its expertise in managing investments in real assets, has initiated a strategic share buyback program. This program, first announced in early April, reflects the Group's commitment to optimizing shareholder value while enhancing its financial positioning within the market....
Continue Reading
Goldman Sachs Predicts Modest 2025 Gains for European Market
Goldman Sachs' Outlook for European Equities Goldman Sachs analysts anticipate modest returns for the STOXX Europe 600 index in the coming years, projecting a 4% price increase and a total return of about 7% when accounting for dividends. This cautious viewpoint suggests a target price of 530 for the index, rising from its current standing of 511. Growth Expectations and...
Continue Reading
How Year-Round Holiday Shopping Is Transforming Retail
Retailers Adapt to Year-Round Holiday Shopping Trends Embracing the holiday spirit well beyond the traditional December confines, retailers are rapidly evolving their strategies. Companies are now recognizing the changing mindset of consumers who enjoy anticipating the holidays much earlier than before. From themed decorations popping up during summer to the concept of...
Continue Reading